The progesterone vaginal pessary
DrugThose patients will receive progesterone vaginal pessary for prevention of preterm delivery in twins pregnancy
Other names: Active drug treatment
NCT Number: NCT02350231
Multiple pregnancies accounted for 1 - 6 % of all births in UK during 2007. More than 98% of these multiple births being twin births . Preterm birth defined as birth occurring prior to 37 weeks of gestation and it was about 15 % of pregnancies in developed world and 12.7 % in the United States.
Preterm birth is the leading cause of infant and neonatal mortality. Premature neonates are at increased risk of developing respiratory distress syndrome, sepsis, intraventricular hemorrhage, and necrotizing enterocolitis.
Twin pregnancy is considered one of the important risk factors of preterm birth. Over distension of uterus may be one of the etiological factors for preterm birth. However, no definite effective interventions have been shown to prevent preterm delivery in twin pregnancy.
Three large randomized trials suggested that progesterone might prevent preterm delivery in high-risk singleton pregnancy especially those with previous preterm delivery or short cervix might be reduced by antenatal progesterone.
Fonseca et al (2007) concluded that women with short cervix are less likely to deliver preterm ≤34 weeks if they are treated with vaginal progesterone.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Phase 2 / Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Those patients will receive progesterone vaginal pessary for prevention of preterm delivery in twins pregnancy
Other names: Active drug treatment
Those patients will receive only tonics
Other names: Placepo
Time frame: from 28 weeks till delivery
Time frame: from 28 weeks till delivery
Time frame: at time of delivery
Time frame: after delivery
Assiut University
Other
Acronym: PPPTP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial DetailsNCT05576207
Anemia of Pregnancy, Birth Weight
Rangpur City, Bangladesh
View Trial DetailsNCT03646578
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Amiens, France
View Trial DetailsNCT07305935
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Multan, Punjab Province, Pakistan
View Trial Details